HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASA Stubs Out E-Cigarette Firm’s Smoking Cessation Claims

Executive Summary

The UK's advertising regulator has ruled that government health statements cannot be used to support smoking cessation claims for unlicensed e-cigarettes.

You may also be interested in...



E-Cigarette Study Suggests Not Limiting Cessation Research To Smokers Interested In Quitting

JAMA study results could spur additional research with subjects from broader pool of candidates for determining whether ENDS products have potential for approval as NRT products. Studies typically limit participants to consumers who want to quit, but expanding pool to include those not interested could add to research results more instances of successful quitting.

US Firms Warned On Linking Vaping With Wellness

Warnings to five marketers don’t state smoking cessation claims and vaping also aren’t related. Rather providing nicotine replacement therapy, the products identified in the warnings were reported as being marketed with claims including “Fight off tumors and alleviate symptoms of chemotherapy."

EA Pharma Enters US And Launches Olyos Group

France's EA Pharma is now operating as part of Olyos Group, alongside Spain’s Drasanvi, Italy’s Stardea and recently-acquired US dietary supplements firm W Group.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel